Business
Item 9 Labs Corp. Announces New Corporate Identity & Branding
Item 9 Labs Corp. Announces New Corporate Identity & Branding.
About this update from Item 9 Labs Corp.
[{"type":"text","content":"\nSCOTTSDALE, Ariz., June 21, 2018 (GLOBE NEWSWIRE) -- Item 9 Labs Corp. (OTC:INLB) (“Item 9 Labs” or the “Company”), a leading provider of comfortable cannabis health solutions for the modern consumer developing innovative products and proprietary delivery platforms, today announced the launch of the Company’s new corporate identity, logo and tagline. Complementing these efforts, Item 9 is launching a new corporate website (www.Item9labscorp.com) and a consumer website (www.Item9labs.com) to effectively connect with the Company’s extensive base of investors and customers.\n Bryce Skalla, Co-Founder & CEO of Item 9 Labs, commented, “In the past few months, we have solidified a key niche within the medical cannabis industry by pairing cutting-edge technologies with high-grade medical marijuana. Our proprietary intra-nasal delivery system is a game-changer for the medical marijuana industry and speaks to our core mission to create comfortable cannabis solutions for today’s modern cannabis user. We are excited to share our unique and evolving position within the Cannabis Bio-Medical space with the launch of our new corporate identity that truly reflects our unique product offerings.” The inclusion of the new tagline “Item 9 Labs creates comfortable cannabis health solutions for the modern consumer by developing innovative products and proprietary delivery platforms” and corporate rebranding is part of the Company’s strategy to introduce today’s most advanced cannabis delivery solutions to the Cannabis Bio-Medical market, expand its business by meeting the increasing needs of medical marijuana consumers, and create a foundation for new growth opportunities. The Company has already achieved several milestones in implementing this strategy, including the Company’s acquisition of BSSD Group, LLC, an Arizona limited liability company, doing business as Item 9 Labs. In conjunction with the acquisition, the Company closed on a material definitive financing agreement in the principal amount of approximately $1.1 million. Subsequent to this, the Company completed a corporate name change to Item 9 Labs Corp., with a corresponding ticker symbol change to ‘INLB.’ In May, the Company executed an intellectual property sales agreement with Health D...